30 Day FDA Drug Development in Ca...
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 22 Clinical Trial Design Nuances for Cannabinoid Therapies

Cannabinoid and Psychedelic Pharmacology and Drug Developmen... di Jim Mitchell and Google NotebookLM

Note sull'episodio

This podcast episode explores the complexities and challenges of clinical trials for cannabinoid therapies. The discussion covers key aspects including:

- Dosing variability and product consistency challenges in plant-derived compounds

- Patient compliance and addressing stigma around cannabis research

- Placebo control difficulties unique to cannabinoid studies

- Special considerations for vulnerable populations like children and pregnant women

The episode also examines promising therapeutic applications including chronic pain management, multiple sclerosis treatment, and potential cancer-related applications.